The Digital Source For China's Tech Innovation Since 2000

Search
Close

VisionX secures over $100m in Series B from Sequoia China, Sherpa, others

October 1, 2021
Source: dealstreetasia.com dealstreetasia.com
News Snapshot:
Ophthalmology-focused medical device supplier VisionX has secured over $100 million for its Series B round of financing, per a company statement on Thursday. The round attracted two new investors – Temasek Holdings and Lake Bleu Capital. Return backers Sequoia Capital China, Green Pine Capital Partners and investment firms – Sherpa Healthcare Partners, 3H Health, Highlight Capital – joined the round. VisionX expects to deploy the capital for talent recruitment, R&D and commercialisation of new candidates. VisionX’s therapy areas target prevention of myopia in teenagers, eyesight correction for adults, ocular surface diseases, optometry diagnostics therapy and equipment, vision nursing and eyesight...
Go To Original Source →
Tags: capital | China | currency | equipment | financing | Fosun | green | Green Pine Capital Partners | health | healthcare | investment | medical | medicine | R&D | recruitment | Renminbi | Sequoia Capital | supplier | Surface | talent | Temasek | venture capital | Yuan

Other Related News:

Apple wants to increase production outside China

May 23, 2022

'BJP limited to Facebook': Arjun Singh rips into ex party after re-joining TMC My Asian Marketplace ChinaPulse.com China News, Data, Media Intelligence and Insights

May 23, 2022

China Can’t Seem to Stop Bitcoin Mining

May 23, 2022

China releases new database on biodiversity

May 23, 2022

Realme Pad X 5G to debut in China on May 26

May 23, 2022

Hongkongers report over 5,000 traffic violations in trial run of police’s new WeChat channel

May 23, 2022

Didi Investors to Vote on NY Delisting After Beijing Crackdown

May 23, 2022

Canada bans Huawei, ZTE from building 5G networks, Beijing says it’s a ‘wrong signal’ –

May 23, 2022

China moots additional security rules for apps that influence public opinion

May 23, 2022
  • Contact Us
  • About Us
  • Corrections and Disclosure
  • Privacy Policy
  • Terms & Conditions
Menu
  • Contact Us
  • About Us
  • Corrections and Disclosure
  • Privacy Policy
  • Terms & Conditions
© 2022 ChinaTechNews.com. A Service of Asia Media Network.
Twitter
Posting....